Effect of novel glucose lowering agents on non-alcoholic fatty liver disease: A systematic review and meta-analysis [0.03%]
新型降糖药对非酒精性脂肪肝病的影响：系统回顾和荟萃分析
Yousaf Zafar,Ahmed Mustafa Rashid,Ahmed Kamal Siddiqi et al.
Yousaf Zafar et al.
Background: The efficacy of novel glucose-lowering drugs in treating non-alcoholic fatty liver disease (NAFLD) in patients with and without type-2 diabetic patients (T2DM) remains unclear. ...
Endoscopic submucosal dissection or piecemeal endoscopic mucosal resection for large superficial colorectal lesions: A cost effectiveness study [0.03%]
内镜下黏膜下挖除术与分片内镜粘膜切除术治疗大范围的浅表性结直肠病变：一项成本效益研究
Scheer Stéphane,Wallenhorst Timothée,Albouys Jérémie et al.
Scheer Stéphane et al.
Background and aims: Endoscopic management is preferred to surgical management for large superficial colorectal lesions. However, the optimal endoscopic resection strategy (piecemeal endoscopic mucosal resection [pEMR] or...
Diagnostic accuracy of apparent diffusion coefficient values combined with γ-glutamyl transpeptidase-to-platelet ratio parameters for predicting hepatitis B-related fibrosis [0.03%]
结合表观扩散系数值及γ-谷氨酰转肽酶-血小板比率参数预测乙型肝炎相关肝纤维化的诊断准确性
Xingxiang Liu,Jian Zhou,Liyao Zhu et al.
Xingxiang Liu et al.
Objectives: The accuracy of non-invasive liver fibrosis diagnosis based on the apparent diffusion coefficient (ADC) value combined with the γ-glutamyl transpeptidase-to-platelet ratio (GPR) model to predict the stage of ...
Association of Helicobacter pylori enrichment in colorectal adenoma tissue on clinical and pathological features of adenoma [0.03%]
幽门螺旋杆菌富集与肠黏膜腺瘤的临床及病理特征的关系研究
Zhaomeng Zhuang,Bingqu Yu,Min Xie et al.
Zhaomeng Zhuang et al.
Objective: To investigate the enrichment of Helicobacter pylori (Hp) in adenoma tissue of patients with colorectal adenoma, and analyze the correlation between the enrichment and the clinical and pathological characterist...
Treatment response, survival, and safety profile of camrelizumab plus apatinib regimen as third-line treatment in metastatic gastric cancer patients [0.03%]
卡瑞利珠单抗联合阿帕替尼治疗三线以上转移性胃癌患者的疗效、生存和安全性分析
Ning Ma,Hui Qiao,Hanchuan Tao et al.
Ning Ma et al.
Background: Camrelizumab, as a PD-1 inhibitor on the market recently, presents favorable therapeutic efficacy in several advanced cancers, while its application in metastatic gastric cancer (mGC) lacks data. This study ai...
Normalization of duodenal mucosa after treatment with Janus kinase (JAK) inhibitor in refractory celiac disease type 2 [0.03%]
Janus激酶抑制剂治疗难治性二类乳糜泻后十二指肠黏膜的正常化
Nicoletta Nandi,Giorgio Alberto Croci,Francesca Gaia Rossi et al.
Nicoletta Nandi et al.
Ribavirin-resistant chronic norovirus infection-associated enteropathy in common variable immunodeficiency. Case report and review of the literature [0.03%]
利巴韦林耐药的慢性诺如病毒相关性肠病与常见多变量免疫缺陷病例报告和文献综述
Gonzalo González-Morcillo,Beatriz Calderón-Hernanz,Joaquín Serrano-López de Las Hazas et al.
Gonzalo González-Morcillo et al.
Chronic Norovirus infection is particularly challenging in patients with common variable immunodeficiency (CVID) because of their inability to achieve viral clearance and the risk of developing enteropathy leading to intestinal villous atro...
Factors associated with non-presentation in a multidisciplinary team meeting for colon cancer: A matched retrospective cohort study in a French area [0.03%]
一项匹配回顾性队列研究：法国结直肠癌多学科团队会议未参会的相关因素分析
Noémi Reboux,Estelle Cadieu,Manon Pruvost-Couvreur et al.
Noémi Reboux et al.
Background: Survival of patients with colon cancer has increased in recent years due to advances in treatment and the implementation of multidisciplinary team meetings (MDTm). However, the organization of MDTm can be impr...
Multicentre match-paired analysis of advanced biliary cancer long-term survivors: The BILONG study [0.03%]
多中心匹配分析的晚期胆道癌长期生存者：BILONG研究
Francesco Caputo,Fabio Gelsomino,Andrea Spallanzani et al.
Francesco Caputo et al.
Background: Advanced biliary cancers (ABC) are aggressive malignancies with a median overall survival (mOS)
Thromboembolism and bleeding in patients with atrial fibrillation and liver disease - A nationwide register-based cohort study: Thromboembolism and bleeding in liver disease [0.03%]
肝病患者房颤栓塞及出血的患病率和风险因素——一项基于全国登记记录的研究：肝病患者的血栓形成和出血
Kamilla Steensig,Manan Pareek,Anne Lund Krarup et al.
Kamilla Steensig et al.
Background: Balancing the risk of thromboembolism and bleeding in patients with liver disease and atrial fibrillation/flutter is particularly challenging. ...